Onconova Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Onconova Therapeutics's estimated annual revenue is currently $3.5M per year.
- Onconova Therapeutics's estimated revenue per employee is $112,903
- Onconova Therapeutics's total funding is $177.9M.
Employee Data
- Onconova Therapeutics has 31 Employees.
- Onconova Therapeutics grew their employee count by 24% last year.
Onconova Therapeutics's People
| Name | Title | Email/Phone |
|---|
Onconova Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Onconova Therapeutics?
Onconova, a privately held Delaware Corporation, is developing innovative products for combating cancer. We are creating novel Solutions for Oncology by combining conventional pharmaceutical science (a small molecule approach) with the latest genomic and genetic technologies for drug discovery and development.
keywords:N/A
$177.9M
Total Funding
31
Number of Employees
$3.5M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Onconova Therapeutics News
... 2022- Insights into the Current Therapies, Emerging Drugs, and Treatment Outlook | Key Players Astex Pharma, Onconova Therapeutics,...
Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com. Posted by admin on Apr 16th, 2022.
Onconova Therapeutics (NASDAQ: ONTX) has recently received a number of price target changes and ratings updates:.
NEWTOWN, Pa., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced the closing of its previously announced underwritten ...
NEWTOWN, Pa. - Onconova Therapeutics, Inc. (NASDAQ: ONTX) ('Onconova'), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of ...
Other Companies in Newtown
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 31 | -11% | N/A |
#2 | $7.5M | 33 | 0% | N/A |
#3 | $3.8M | 33 | -6% | N/A |
#4 | $4.1M | 35 | 3% | N/A |
#5 | $9.9M | 35 | 3% | N/A |